Apheresis systems have been used in inflammatory bowel disease with a view to
immunomodulation. The technique employs a system of white cell extraction, filtration and …

Leukocyte apheresis works by purifying distinct populations of active leukocytes and by
modifying inflammatory mediators. Based on their theoretical immunomodulatory effect …

Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …

Objective. Selective leukocyte apheresis is a new type of non-pharmacological treatment for
patients with active ulcerative colitis and Crohn's disease. Preliminary data have indicated …

In this review the current aspects concerning the application of leukocytapheresis in patients
with inflammatory bowel disease are briefly discussed. Leukocytapheresis has already been …

In patients with inflammatory bowel disease (IBD), centrifugation has been attempted to
remove leukocyte components from whole blood; however, the use of selective filters has …

Ulcerative colitis and Crohn's disease are inflammatory bowel diseases with a chronic
relapsing course. Management of both conditions is far from being fully satisfactory. For this …

Leukocytes are thought to play an important role in the pathogenesis of inflammatory bowel
diseases; granulocyte–monocyte adsorptive (GMA) apheresis, an extracorporeal technique …

Background Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte
and monocyte apheresis (GMA) with Adacolumn® was introduced as a nonpharmacologic …

Initially used to treat rheumatoid arthritis, nonselective therapeutic leukocytapheresis was
applied to the treatment of inflammatory bowel disease (IBD) as early as the 1980s. Since …